D
Dingke Medical Technology ( Suzhou )
Vascular intervention devices for complex medical procedures
About Dingke Medical Technology ( Suzhou )
Founded in 2015 by Yulin Weng, Dingke Medical Technology is a medical device company headquartered in Suzhou, China, specializing in solutions for vascular intervention. The company develops and manufactures a portfolio of products for coronary, peripheral, and neurovascular interventions. Its product line includes various balloon catheters, such as conventional, high-pressure, scoring, and drug-coated scoring balloons. A key proprietary technology is its Directional Scoring, which has shown significant clinical benefits in studies.
Dingke Medical operates a 12,000㎡ manufacturing center and a 9,200㎡ R&D hub, employing over 300 people. The company has established a global quality management system, securing certifications such as ISO 13485, MDSAP, and CE MDR. It has also entered into strategic collaborations with established international firms like Medtronic and Asahi Intecc. The business model is focused on the R&D, manufacturing, and sale of these specialized medical devices to healthcare providers globally, aiming to improve patient outcomes in vascular surgery.
The company has successfully completed six funding rounds, raising over USD 100 million from investors including Qiming Venture Partners, Legend Capital, and CICC Capital. This capital is being used to accelerate the global commercialization of its product pipeline. Dingke Medical has received multiple accolades, including being named a National High-tech Enterprise in China and a "Venture50 Rising Star" in 2023.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 23.0/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Surgery, Catheters, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES E✓Equity / VC | Jun 2024 | — | — | Legend Capital · Qiming Venture Partners | ↗ |
| OtherOther financing | May 2023 | $0 | — | Qiming Venture Partners | — |
Growth signals
Latest recorded traffic for Dingke Medical Technology ( Suzhou ) is 140 monthly website visits, down 90% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Dingke Medical Technology ( Suzhou ) in the Suzhou Shi ecosystem
The Dingke Medical Technology ( Suzhou ) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Qiming Venture Partners
China Growth Capital
Jinbang Capital
Series B and later2 investors entered at this stage
- SGShenZhen GTJA Investment Group
Legend Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Dingke Medical Technology ( Suzhou ) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Dingke Medical Technology ( Suzhou )’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







